NPI: 1790723831 · BRANDON, MS 39042 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,738 | $292K |
| 2019 | 11,122 | $272K |
| 2020 | 13,237 | $277K |
| 2021 | 9,945 | $242K |
| 2022 | 11,688 | $216K |
| 2023 | 6,188 | $249K |
| 2024 | 2,035 | $160K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,788 | 2,136 | $1.35M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,086 | 1,190 | $237K |
| A4657 | Syringe, with or without needle, each | 3,517 | 1,541 | $46K |
| 83970 | 1,180 | 968 | $27K | |
| J1756 | Injection, iron sucrose, 1 mg | 4,354 | 1,143 | $16K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 67 | 37 | $9K |
| 82728 | 695 | 583 | $6K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 8,742 | 869 | $5K |
| 83550 | 478 | 434 | $4K | |
| 83540 | 697 | 582 | $3K | |
| 85041 | 1,308 | 1,128 | $2K | |
| 85048 | 1,301 | 1,122 | $2K | |
| 85045 | 468 | 385 | $928.46 | |
| 82607 | 50 | 49 | $702.70 | |
| 82108 | 37 | 36 | $433.16 | |
| 82746 | 20 | 19 | $264.78 | |
| 90674 | 14 | 14 | $165.96 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 445 | 227 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 677 | 442 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 29 | 28 | $0.00 |